Risk groups
Risk group . | Response . | Survival . | ||||
---|---|---|---|---|---|---|
Definition . | N (%) . | % CR . | Definition . | N (%) . | Median, wk . | |
Age <60 | ||||||
Favorable | No poor prognostic factors* | 144 (22) | 85 | Age ≤ 40 and de novo AML | 144 (22) | 171 |
Intermediate | 1 poor prognostic factor* | 303 (46) | 74 | Age > 40 or sAML (but not both) | 314 (48) | 67 |
Unfavorable | 2 or 3 poor prognostic factors* | 206 (32) | 46 | Age > 40 and sAML | 195 (30) | 46 |
P < .001† | P < .001‡ | |||||
Age ≥60 | ||||||
Favorable | Age < 70 and de novo AML or age < 70, sAML, and WBC ≤ 5000 | 284 (43) | 63 | Age < 70 and WBC ≤ 5000 | 194 (29) | 41 |
Intermediate | Age ≥ 70 and de novo AML or age ≥ 70, sAML, and WBC ≤ 5000 | 232 (35) | 55 | Age ≥ 70 or WBC > 5000 (but not both) | 331 (50) | 33 |
Unfavorable | sAML and WBC > 5000 | 148 (22) | 37 | Age ≥ 70 and WBC > 5000 | 139 (21) | 21 |
P < .001† | P < .001‡ |
Risk group . | Response . | Survival . | ||||
---|---|---|---|---|---|---|
Definition . | N (%) . | % CR . | Definition . | N (%) . | Median, wk . | |
Age <60 | ||||||
Favorable | No poor prognostic factors* | 144 (22) | 85 | Age ≤ 40 and de novo AML | 144 (22) | 171 |
Intermediate | 1 poor prognostic factor* | 303 (46) | 74 | Age > 40 or sAML (but not both) | 314 (48) | 67 |
Unfavorable | 2 or 3 poor prognostic factors* | 206 (32) | 46 | Age > 40 and sAML | 195 (30) | 46 |
P < .001† | P < .001‡ | |||||
Age ≥60 | ||||||
Favorable | Age < 70 and de novo AML or age < 70, sAML, and WBC ≤ 5000 | 284 (43) | 63 | Age < 70 and WBC ≤ 5000 | 194 (29) | 41 |
Intermediate | Age ≥ 70 and de novo AML or age ≥ 70, sAML, and WBC ≤ 5000 | 232 (35) | 55 | Age ≥ 70 or WBC > 5000 (but not both) | 331 (50) | 33 |
Unfavorable | sAML and WBC > 5000 | 148 (22) | 37 | Age ≥ 70 and WBC > 5000 | 139 (21) | 21 |
P < .001† | P < .001‡ |